Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Effect of amelogenin ECM protein on the healing of chronic leg ulcers with atrophie blanche.

Fogh K, Nielsen CB, Dam W.

J Wound Care. 2012 Dec;21(12):612-4.

PMID:
23299272
2.

Effect of amelogenin extracellular matrix protein and compression on hard-to-heal venous leg ulcers.

Vowden P, Romanelli M, Price P.

J Wound Care. 2007 May;16(5):189-95.

PMID:
17552400
3.

Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche.

Mimouni D, Ng PP, Rencic A, Nikolskaia OV, Bernstein BD, Nousari HC.

Br J Dermatol. 2003 Apr;148(4):789-94.

PMID:
12752140
4.

New insights into therapy by mathematical analysis: recalcitrant granulated improved more than sclerotic venous leg ulcers with amelogenin treatment.

Renner R, Simon JC.

J Dermatol Sci. 2012 Jul;67(1):15-9. doi: 10.1016/j.jdermsci.2012.04.007. Epub 2012 Apr 25.

PMID:
22608215
5.

The effect of amelogenins (Xelma) on hard-to-heal venous leg ulcers.

Vowden P, Romanelli M, Peter R, Boström A, Josefsson A, Stege H.

Wound Repair Regen. 2006 May-Jun;14(3):240-6.

PMID:
16808801
7.

Risk factors related to the failure of venous leg ulcers to heal with compression treatment.

Milic DJ, Zivic SS, Bogdanovic DC, Karanovic ND, Golubovic ZV.

J Vasc Surg. 2009 May;49(5):1242-7. doi: 10.1016/j.jvs.2008.11.069. Epub 2009 Feb 23.

8.

The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts.

Lantis JC 2nd, Marston WA, Farber A, Kirsner RS, Zhang Y, Lee TD, Cargill DI, Slade HB.

J Vasc Surg. 2013 Aug;58(2):433-9. doi: 10.1016/j.jvs.2012.12.055. Epub 2013 Apr 12.

9.

Effect of amelogenin extracellular matrix protein and compression on hard-to-heal venous leg ulcers: follow-up data.

Romanelli M, Kaha E, Stege H, Wnorowski JW, Vowden P, Majamaa H, Lazaro JL.

J Wound Care. 2008 Jan;17(1):17-8, 20-3.

PMID:
18210952
10.

A trial to assess the efficacy and tolerability of Hyalofill-F in non-healing venous leg ulcers.

Colletta V, Dioguardi D, Di Lonardo A, Maggio G, Torasso F.

J Wound Care. 2003 Oct;12(9):357-60.

PMID:
14601230
11.

Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers.

Senet P, Bon FX, Benbunan M, Bussel A, Traineau R, Calvo F, Dubertret L, Dosquet C.

J Vasc Surg. 2003 Dec;38(6):1342-8.

13.
14.

Community clinics for leg ulcers and impact on healing.

Moffatt CJ, Franks PJ, Oldroyd M, Bosanquet N, Brown P, Greenhalgh RM, McCollum CN.

BMJ. 1992 Dec 5;305(6866):1389-92.

15.

Initial rate of healing predicts complete healing of venous ulcers.

Tallman P, Muscare E, Carson P, Eaglstein WH, Falanga V.

Arch Dermatol. 1997 Oct;133(10):1231-4.

PMID:
9382561
16.

Modelling the relative cost-effectiveness of amelogenin in non-healing venous leg ulcers.

Guest JF, Nagy E, Sladkevicius E, Vowden P, Price P.

J Wound Care. 2009 May;18(5):216, 218-24. Review.

PMID:
19440174
18.

Fibrinolytic abnormalities in two different cutaneous manifestations of venous disease.

Margolis DJ, Kruithof EK, Barnard M, Howe K, Lazarus GS.

J Am Acad Dermatol. 1996 Feb;34(2 Pt 1):204-8.

PMID:
8642083
19.

Impact of protein deficiency on venous ulcer healing.

Legendre C, Debure C, Meaume S, Lok C, Golmard JL, Senet P.

J Vasc Surg. 2008 Sep;48(3):688-93. doi: 10.1016/j.jvs.2008.04.012. Epub 2008 Jun 25.

Supplemental Content

Support Center